Overview

A Drug Interaction Study of LY3154207 in Healthy Participants

Status:
Completed
Trial end date:
2019-12-28
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn more about the safety and side effects of LY3154207 and fluconazole (anti-fungal medication), when taken together by healthy participants. The study will last from nine to 11 weeks for each participant.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Fluconazole